Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Colonization factor antigen I (CFA/I) is a fimbrial protein complex expressed on the surface of enterotoxigenic *Escherichia coli* (ETEC). It mediates bacterial attachment to the small intestinal mucosa, facilitating colonization and subsequent toxin delivery, leading to diarrheal disease. CFA/I consists of a major stalk subunit (CfaB) and a minor tip adhesin (CfaE), with CfaE being crucial for specific binding and a promising target for vaccine development.
Inhibition of bacterial adherence to intestinal epithelium
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Colonization Factor Antigen I.